GlaxoSmithKline Newsroom

GlaxoSmithKline (GSK) Gets a Hold From UBS

TipRanksApr 30 10:05 ET

Jefferies Remains a Hold on GlaxoSmithKline (GSK)

TipRanksApr 30 07:23 ET

J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)

TipRanksApr 30 04:45 ET

Research Alert: Q1 2025 Results Beat Estimates As Specialty Medicines Offset Weaker Vaccines

MT NewswiresApr 30 04:16 ET

GlaxoSmithKline (GSK) Gets a Hold From UBS

TipRanksApr 23 04:31 ET

J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)

TipRanksApr 22 14:16 ET

BNP Paribas Initiates GSK at Neutral Rating, $35.25 Price Target

MT NewswiresApr 15 12:34 ET

GlaxoSmithKline (GSK) Receives a Hold From Barclays

TipRanksApr 14 02:10 ET

GlaxoSmithKline (GSK) Receives a Buy From Bernstein

TipRanksApr 3 07:43 ET

J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)

TipRanksMar 28 05:00 ET

Deutsche Bank Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TipRanksMar 25 05:42 ET

Barclays Remains a Hold on GlaxoSmithKline (GSK)

TipRanksMar 24 03:30 ET

Cautious Outlook on GlaxoSmithKline Amid Competitive and Financial Challenges Justifies Sell Rating

TipRanksMar 21 05:37 ET

GlaxoSmithKline (GSK) Gets a Hold From Barclays

TipRanksMar 3 02:05 ET

GlaxoSmithKline (GSK) Gets a Buy From Bernstein

TipRanksFeb 20 07:14 ET

Goldman Sachs Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)

TipRanksFeb 17 05:56 ET

TD Cowen Maintains GlaxoSmithKline(GSK.US) With Hold Rating, Maintains Target Price $45

Moomoo NewsFeb 12 15:31 ET

Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)

TipRanksFeb 10 06:14 ET

Hold Rating on GlaxoSmithKline: Balancing Promising Guidance With Existing Challenges

TipRanksFeb 6 05:09 ET

Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)

TipRanksFeb 6 01:28 ET